TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -2 | 2 | -5 | -20 | -20 | -36 | -13 |
| S | %wins | 100 | 50 | 50 | 100 | 50 | 100 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/15/08 17:12 | 3/22/05 | ANX | Adventrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Levine Evan | CA | DO | CEO,P | S.m | -34 | 2.28 | 0 | -15 | 0 | 4,390 | D | -90 | -80 | -34 | 15 | -20 | -2 | -10 | -6 | 0 | 9 | 2 | -23 | -55 | -62 |
2/9/07 21:03 | 2/6/07 | QTXB | Quantrx Biomedical Corp | NV | Health | MdEq | Surgical & Medical Instrument | Levine Evan | CA | DT | S | -695 | 0.7000 | 0 | -993 | -21 | 3,790 | I | |||||||||||||||
9/14/05 18:01 | 9/12/05 | ANX | Adventrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Levine Evan | CA | DO | P,CEO | S.dm | -193 | 3.55 | 0 | -54 | -1 | 4,194 | I | 110 | 170 | 214 | 27 | 20 | -7 | -9 | -5 | -4 | -6 | -12 | -16 | 16 | -10 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |